Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
Search: 
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
_
Program Contents
bullet Topic Home
bullet About IDSR
bullet IDSR Partners
bullet Countries
bullet Focus areas
bullet Resources
bullet Contact
Quick Links

bullet IDSR lab meeting,
Atlanta, GA
September 2006
English PDF | French PDF
  bullet Progress with IDSR implementation
  bullet IDSR core indicators
 
Contact Info
Clifton Road NE, MS C-12
Atlanta, GA 30333
Phone: 1(404) 639-2416
Fax: 1(404) 639-3106
_
Integrated Disease Surveillance and Response

Tuberculosis

Introduction
bulleted list item, level 1

The district-level TB surveillance objective is to follow trends in pulmonary TB cases and indicators of complete treatment (which will render the patient non-infectious).

bulleted list item, level 1 There are two main forms of the disease tuberculosis, namely pulmonary TB and extra pulmonary TB.
bulleted list item, level 2 The pulmonary form of the disease, which spreads predominantly by droplet infection through coughing or sneezing, tends to be the infectious form. It is easily transmitted from person-to-person.
bulleted list item, level 2 Extra-pulmonary TB that affects all other human organs apart from the lung tissue is rarely infectious.
bulleted list item, level 2 From a public health perspective pulmonary TB is the primary focus for interventions. Among the pulmonary TB form, there are those with high bacillary load which are easily detected by light microscopic examination of sputum specimens (known as smear-positive PTB), and those with relatively low bacillary load which are not so easily detected by light microscopy (known as smear-negative PTB). Smear-positive pulmonary TB is more infectious than smear-negative pulmonary TB.
bulleted list item, level 2 On average, a single smear-positive pulmonary TB case leads to 10-15 new infections in a year and 5-7 new clinically apparent pulmonary TB cases within a year.
bulleted list item, level 2

HIV will cause the number of TB cases in a district to increase, even at relatively low levels of HIV infection in the district. In fact, the epidemiology of TB cases in a district may be a good indicator of the level of HIV, the geographic spread, and whether the HIV epidemic is concentrated in high risk populations or has spread widely in the general population.

 

Laboratory analysis
bulleted list item, level 1 Diagnosis of TB is based on bacteriological examination of sputum specimens for Acid Fast Bacilli (AFB) stained by the Ziehl-Neelsen method, using a light microscope. Three sputum specimens from a TB suspect, collected over two consecutive days must be examined.
bulleted list item, level 1

By definition, a new smear-positive pulmonary TB case is diagnosed when one of the following two scenarios emerge: 1) two positive smear results (out of the 3), 2) one positive smear result supported by suggestive radiological evidence, and a decision by a Medical Officer to treat with a complete course of anti-TB chemotherapy. The positive predictive value of a diagnosis of new smear-positive pulmonary TB using the two criteria above is approximately 80% for patients with highly infectious pulmonary TB. The sensitivity and specificity values for sputum smear microscopy are generally high (>70%).

 

Analysis of time, place, and person.
bulleted list item, level 1 New Case Notification Classifications.
  bulleted list item, level 2 Approximately 65% of all pulmonary cases registered in a quarter should be smear-positive.
  bulleted list item, level 2 If the percentage of smear-positive cases is significantly lower, the quality of diagnosis of pulmonary TB may be poor.
  bulleted list item, level 2 There should be approximately a 1 to 1 relationship between the number of new smear-positive cases and the number of new smear-negative cases and extra-pulmonary cases combined. Should this ratio be grossly distorted, then the quality of diagnosis may again be suspect. For example, extra-pulmonary or smear-negative pulmonary TB may be over-diagnosed.
  bulleted list item, level 2 If there is an increasing number of extra-pulmonary TB cases (in the absence of increasing over-all TB or smear-positive pulmonary cases), one should also consider an increase in HIV since HIV causes slightly more extra-pulmonary cases than pulmonary cases. With HIV both extra-pulmonary and pulmonary will increase, but extra-pulmonary may increase slightly faster.
  bulleted list item, level 2 If the ratio of smear-negative cases plus extra-pulmonary cases to smear-positive cases is too high, one should examine the quality of laboratory diagnosis.
  bulleted list item, level 2 A decreasing trend of smear-positive PTB cases could indicate less reliance on smear microscopy for diagnosis leading to over-diagnosis of smear-negative and extra-pulmonary TB. For instance, there could be an over-diagnosis of smear-negative cases by the overuse of radiological examination by a clinician who is not familiar with the recommendations of the national TB programme guidelines.
  bulleted list item, level 2 If there is an increasing number of smear-negative pulmonary cases (in the absence of increasing over-all TB or smear-positive pulmonary cases), the district team should consider: a problem with lab--falsenegative smears, and over-use or over-reading of x-rays or other methods of diagnosing pulmonary TB.
bulleted list item, level 1 Category of Retreatment cases
  bulleted list item, level 2 Under a well-performing program, the proportion of registered TB cases that result in relapse, failures, or retreatment after interruption should remain stable or decline with time.
  bulleted list item, level 2 An increasing proportion of registered TB cases that result in retreatment usually indicates a decline in the performance of the TB program. An increasing proportion of registered TB cases that result in relapse can indicate increasing drug resistance.
bulleted list item, level 1 Age and gender of new smear-positive pulmonary cases.
  bulleted list item, level 2 In the African Region, most cases occur in the 15-49 age group. Under the age of 15 years, the prevalence of disease is the same in both males and females. However, after 15 years, more males are affected than females. Thus, if the sex ratio before 15 years in a district is high in favor of males it may indicate poor accessibility of TB services for female children.
  bulleted list item, level 2 Where TB control is effective, the age distribution of TB cases shifts to older age groups.
  bulleted list item, level 2 Changes in age distribution of TB cases (increases in 15-24 year old females) may reflect the epidemiology of HIV in the district.
bulleted list item, level 1 Cohort Analysis of Treatment Results
  bulleted list item, level 2 In calculating the cohort analysis of treatment results, the denominator is all registered patients. The percentage of registered patients that are evaluated and the percentage of all registered patients that are smear negative at the end of treatment (cured) are important indicators that the district should monitor.
  bulleted list item, level 2 The percentage of registered patients that are cured should increase to 85%. It may be difficult to reach 85% "cured" in districts with high rates of HIV since many patients in each treatment cohort will die.
  bulleted list item, level 2 An increasing proportion of patients registered but not evaluated, with failure or who interrupted treatment, is a warning sign indicating potential program problems.
bulleted list item, level 1 Case fatality ratio
  bulleted list item, level 2

In the absence of HIV infection, the case fatality ratio is approximately 0.15, but this is higher (0.20-0.30) in the presence of HIV infection. If case fatality increases, one should consider increasing HIV infection, increasing TB drug resistance, or poor program performance as the cause.

 

Public health action and targets.
bulleted list item, level 1 For control of TB in the African Region, WHO recommends the DOTS strategy (Directly Observed Therapy, Short-course). This is a cost-effective strategy based on early case detection primarily through microscopic diagnosis of sputum specimens and early treatment using a standardized combination of antimicrobials administered over a relatively short period (e.g. six months) under direct observation by a trained treatment supporter. When correctly applied, this ensures cure of infectious cases (and other cases) and thereby reduces the transmission of the disease.
bulleted list item, level 1 For individual patients, DOTS treatment results in a cure rate of >90% when correctly given.
bulleted list item, level 1 DOTS can result in a 10% decline in smear-positive PTB cases per annum in a district in the absence of HIV infection.
bulleted list item, level 1 The first priority of every TB program must therefore be to direct resources towards identifying the sick infectious cases (smear-positive pulmonary TB cases) so they can be cured. Correct implementation of DOTS in a district should result in cure rates of 80-85%.

 

Reported New Pulmonary Smear+ Cases by Age Group
Reported New Pulmonary Smear+ Cases by Age Group

 

TB Person Analysis

 
Yr
Yr
Yr
n (%)
n (%)
n (%)
Case Notifications
Pulmonary - Smear+ New Case      
Pulmonary - Smear+ Relapse      
Pulmonary - Smear Negative      
Extra-pulmonary      
Total      
Category of Retreatment cases
Relapses      
Failures      
Retreatment after interruption      
Total      
Age of new pulm. smear+ cases
 
M
F
M
F
M
F
0-14            
15-24            
25-34            
35-44            
45-54            
55-64            
65+            
Total            

 

Cohort analysis done on patients registered in the previous year

 
Yr
Yr
Yr
 
Smear Conversion
New pulm.
smear+
(at 2 mo)
Re-rx
smear+
(at 3 mo)
New pulm.
smear+
(at 2 mo)
Re-rx
smear+
(at 3 mo)
New pulm.
smear+
(at 2 mo)
Re-rx
smear+
(at 3 mo)
No. new sputum+ converted
by 2-3 mo.
           
No. new sputum+ evaluated with
sputum by end of 3rd month
(Denominator)
           
 
Treatment Results
New
pulm.
smear+
Re-rx
smear+
New
pulm.
smear+
Re-rx
smear+
New
pulm.
smear+
Re-rx
smear+
Total registered            
Total evaluated            
Smear neg. at end of treatment
(cured)
           
Complete treatment, but smear
not done at end of treatment
           
Died            
Failure            
Interrupted treatment            
Transferred out            

 

Cohort analysis on patients registered, semiannual

 
1
2
1
2
1
2
Total registered  
Total evaluated            
Smear negative at
end of treatment
           
Complete treatment,
smear not done at end
           
             
             
 
yr 1
yr 1
yr 1
 
 
Date: July 14, 2005
Content source: Coordinating Center for Infectious Diseases / Division of Bacterial and Mycotic Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435